Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03732495
Title Study of the Efficacy of Lenvatinib Combined With Denosumab in the Treatment of Patients With Predominant Bone Metastatic Radioiodine Refractory Differentiated Thyroid Carcinomas (LENVOS)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Centre Leon Berard

thyroid gland follicular carcinoma

thyroid gland papillary carcinoma

differentiated thyroid gland carcinoma


Denosumab + Lenvatinib

Age Groups: adult | senior
Covered Countries FRA

No variant requirements are available.